- Publish with us
- Current issue
- Online first
- Archive
- InSight+
- Topicskeyboard_arrow_down
- Anatomy and physiology
- Anesthesia, analgesia and pain
- COVID-19
- Cardiovascular diseases
- Complementary therapies
- Diagnostic techniques and procedures
- Digestive system diseases
- Emergency medicine
- Endocrine system diseases
- Environment and public health
- Ethics
- Ethics and law
- Eye diseases
- General medicine
- Gerontology
- Global health
- Health occupations
- Health services administration
- Hematologic diseases
- History and humanities
- Immune system diseases
- Indigenous health
- Infectious diseases
- Information science
- Medical education
- Medical genetics
- Men's health
- Mental disorders
- Musculoskeletal diseases
- Neoplasms
- Nervous system diseases
- Nutritional and metabolic diseases
- Occupational diseases
- Otorhinolaryngologic diseases
- Paediatrics
- Palliative care
- Pediatric medicine
- Pharmaceutical preparations
- Poisoning
- Public and environmental health
- Rehabilitation
- Respiratory tract diseases
- Rheumatology
- Sexual health
- Skin and connective tissue diseases
- Social determinants of health
- Sports medicine
- Statistics, epidemiology and research design
- Substance-related disorders
- Substance‐related disorders
- Surgical procedures, operative
- Urologic diseases
- Vascular diseases
- Women's health
- Wounds and injuries
- Article typeskeyboard_arrow_down
- Podcasts
- Jobs board
- Connected
Connect
Advertisement
Video
Volume , Issue - 12 May 2025
Ms Jane Halton, PSM, Secretary of the Department of Health and Ageing delivers a speech on behalf of The Hon Tanya Plibersek MP discussing CTAG and the investigator-initiated clinical trials sector
Advertisement
